Monoamine oxidase inhibitors in the management of Parkinson’s disease
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 4 Monoamine oxidase inhibitors in the management of Parkinson’s disease Sven-Eric Pålhagen Introduction Monoamine oxidase B (MAO-B) inhibitors have again become relevant as a good…
